SETIAWAN, S. I., & ASCOBAT, P. (2019). ADVERSE REACTIONS TO FIRST-LINE ANTI-TUBERCULOSIS DRUGS AS A RISK FACTOR OF PULMONARY TUBERCULOSIS TREATMENT DEFAULT IN JAKARTA, INDONESIA. International Journal of Applied Pharmaceutics, 11(6), 80–83. https://doi.org/10.22159/ijap.2019.v11s6.33551